Please assess the completion status of the following clinical trial:

Trial Title: Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in Fontan Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Single ventricle physiology congenital heart disease status post Fontan palliation~* Undergoing clinically-indicated liver biopsy~* Ability to tolerate 60 minutes in an MRI scanner without sedation~Exclusion Criteria:~* Known contraindication to MR imaging (e.g., implanted non-MRI compatible device)~* Known or suspected pregnancy. Female subjects of child bearing potential will undergo urine pregnancy testing prior to imaging

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Fontan patients (Type: None): Pediatric and adult Fontan patients will undergo MRI (Magnetic Resonance Imaging) of the liver using novel, non-contrast MRI methods. These MR methods will be used to detect, discriminate and measure liver fibrosis and congestion. The resulting quantitative imaging measurements will be correlated with histopathologic data obtained from a clinically-indicated liver biopsy.

Based on this trial design, predict the completion outcome and termination type (if applicable).